In a daring move, Sanofi cut Lantus' advertised price by 78%, to $96 for prefilled pens and $64 for the 10-milliliter vial.

Sanofi cut the list price of Lantus by 78% to $96 for the prefilled pens and $64 for the 10-milliliter vial starting Jan. 1. It reduced the list price of its short-acting Apidra insulin by 70%.

Sanofi cut the list price of Lantus by 78% to $96 for the prefilled pens and $64 for the 10-milliliter vial starting January 1. It reduced the list price of its short-acting Apidra insulin by 70%.

Sanofi cut the list price of Lantus by 78% to $96 for the prefilled pens and $64 for the 10-milliliter vial starting January 1. It reduced the list price of its short-acting Apidra insulin by 70%.

Sanofi cut the list price of Lantus by 78% to $96 for the prefilled pens and $64 for the 10-milliliter vial starting January 1. It reduced the list price of its short-acting Apidra insulin by 70%.

Sanofi cut the list price of Lantus by 78% to $96 for the prefilled pens and $64 for the 10-milliliter vial starting January 1. It reduced the list price of its short-acting Apidra insulin by 70%.